Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a single stem cell transplant free beta-thalassemia patients from lifelong transfusions?

NCT ID NCT04390971

First seen Feb 11, 2026 · Last updated May 25, 2026 · Updated 10 times

Summary

This early study tested a new stem cell treatment called ET-01 in 3 people with transfusion-dependent beta-thalassemia, a serious blood disorder that requires regular blood transfusions. The treatment uses the patient's own stem cells, which are modified and then given back to help the body produce healthy red blood cells. The main goals were to check safety and see if the transplant could reduce or eliminate the need for transfusions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSFUSION DEPENDENT BETA-THALASSAEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, 563000, China

  • Institute of Hematology & Blood Diseases Hospital

    Tianjin, Tianjin Municipality, 300020, China

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, 550004, China

Conditions

Explore the condition pages connected to this study.